Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease.
Carella
A M
AM
Beltrami
G
G
Carella
M
M
Corsetti
M T
MT
Scalzulli
R P
RP
Greco
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016879:Salvage Therapy; D014184:Transplantation, Homologous / Q000379:methods; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine